ARKK Holdings of Twist Bioscience (TWST) - Updated Daily
Earnings Date: Thursday, Feb 4th
Key Statistics
| Description | |
|---|---|
| Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. | |
| Website | |
| https://www.twistbioscience.com/ | |
| 📅 Next Earnings Date | |
| February 4th 2021 |
Research Notes and Commentary for TWST
No Research Notes Found for TWST